220 related articles for article (PubMed ID: 33960245)
1. Enhancing the
El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
Drug Deliv; 2021 Dec; 28(1):906-919. PubMed ID: 33960245
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole for Topical Treatment of Skin Carcinogenesis: Efficacy Enhancement by Lipid Nanocapsule Formulations.
El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
J Biomed Nanotechnol; 2022 Jan; 18(1):97-111. PubMed ID: 35180903
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis.
El-Sheridy NA; Ramadan AA; Eid AA; El-Khordagui LK
Colloids Surf B Biointerfaces; 2019 Sep; 181():623-631. PubMed ID: 31202972
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
Eissa MM; El-Moslemany RM; Ramadan AA; Amer EI; El-Azzouni MZ; El-Khordagui LK
PLoS One; 2015; 10(11):e0141788. PubMed ID: 26574746
[TBL] [Abstract][Full Text] [Related]
5. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
El-Moslemany RM; Eissa MM; Ramadan AA; El-Khordagui LK; El-Azzouni MZ
Acta Trop; 2016 Jul; 159():142-8. PubMed ID: 27039667
[TBL] [Abstract][Full Text] [Related]
6. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers.
Yu G; Ali Z; Sajjad Khan A; Ullah K; Jamshaid H; Zeb A; Imran M; Sarwar S; Choi HG; Ud Din F
Int J Nanomedicine; 2021; 16():3255-3273. PubMed ID: 34012260
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
10. Multi-Reservoir Phospholipid Shell Encapsulating Protamine Nanocapsules for Co-Delivery of Letrozole and Celecoxib in Breast Cancer Therapy.
Elzoghby AO; Mostafa SK; Helmy MW; ElDemellawy MA; Sheweita SA
Pharm Res; 2017 Sep; 34(9):1956-1969. PubMed ID: 28643236
[TBL] [Abstract][Full Text] [Related]
11. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
Safwat S; Hathout RM; Ishak RA; Mortada ND
J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
[TBL] [Abstract][Full Text] [Related]
12. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
Ding B; Chen P; Kong Y; Zhai Y; Pang X; Dou J; Zhai G
J Drug Target; 2014 Jan; 22(1):67-75. PubMed ID: 24099639
[TBL] [Abstract][Full Text] [Related]
16. Intracellular availability of poorly soluble drugs from lipid nanocapsules.
Bohley M; Haunberger A; Goepferich AM
Eur J Pharm Biopharm; 2019 Jun; 139():23-32. PubMed ID: 30851353
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
[TBL] [Abstract][Full Text] [Related]
18. Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.
Cé R; Lavayen V; Couto GK; De Marchi JGB; Pacheco BZ; Natividade LA; Fracari TO; Ciocheta TM; de Cristo Soares Alves A; Jornada DS; Guterres SS; Seixas F; Collares T; Pohlmann AR
Pharm Res; 2021 Feb; 38(2):301-317. PubMed ID: 33608808
[TBL] [Abstract][Full Text] [Related]
19. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
